Sociedad Quimica y Minera S.A. Common Stock vs GeneDx Holdings Corp — how do they compare? Sociedad Quimica y Minera S.A. Common Stock trades at $63.91 (market cap $18.43B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Sociedad Quimica y Minera S.A. Common Stock is far larger — about 9.1× GeneDx Holdings Corp's market cap, and Sociedad Quimica y Minera S.A. Common Stock pays a 3.76% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sociedad Quimica y Minera S.A. Common Stock for 1 Days and GeneDx Holdings Corp for 19 Days on average.
| SQM | WGS | |
|---|---|---|
Market Cap | $18.43B | $2.02B |
Volume | 710,989 | 734,640 |
Sector | Basic Materials | Health |
52-Week High | $95.31 | $167.51 |
52-Week Low | $40.77 | $34.51 |
Typical Hold Time | 1 Days | 19 Days |
Enterprise Value | $19.29B | $2.05B |
Dividend Yield | 3.76% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SQM is a mining and chemical company operating in northern Chile. Its businesses include lithium, iodine, specialty plant nutrition, potassium, solar salts, and industrial chemicals.
Read more on SQM →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →